This information was published on 2025-05-05T09:00:02 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2540695 (IR 1850478) |
| (220) |
19 Mar 2025
|
| (300) |
US, 13 Nov 2024, 98850671
|
| (511) (510) |
Class 5
Pharmaceutical product and therapeutic pharmaceutical product for Netherton Syndrome, and rare and orphan diseases. Class 42 Pharmaceutical development of therapeutic pharmaceuticals for the treatment of diseases. |
| (540) | NETHERTON NOW |
| (550) | Word |
| (730) |
Quoin Pharmaceuticals, Inc.
|
Find out more about publications on the About page.